|
| 1 |
|
Conditions listed in this trial |
|
|
Cancer-Related Problem/Condition |
|
|
Childhood Germ Cell Tumor |
|
|
Chordoma |
|
|
Extragonadal Germ Cell Tumor |
|
|
Kidney Cancer |
|
|
Liver Cancer |
|
|
Neuroblastoma |
|
|
Ovarian Cancer |
|
|
Retinoblastoma |
|
|
Sarcoma |
|
|
Testicular Germ Cell Tumor |
|
| 2 |
|
Additional conditions recognized in this trial |
|
|
Carcinoma, Renal Cell |
|
|
Central Nervous System Neoplasms |
|
|
Kidney Neoplasms |
|
|
Liver Neoplasms |
|
|
Neoplasms, Germ Cell and Embryonal |
|
|
Nervous System Neoplasms |
|
|
Ovarian Neoplasms |
|
| 3 |
|
More general conditions related to this trial |
|
|
Adenocarcinoma |
|
|
Adnexal Diseases |
|
|
Carcinoma |
|
|
Digestive System Diseases |
|
|
Digestive System Neoplasms |
|
|
Endocrine Gland Neoplasms |
|
|
Endocrine System Diseases |
|
|
Eye Diseases |
|
|
Eye Neoplasms |
|
|
Genital Diseases, Female |
|
|
Genital Neoplasms, Female |
|
|
Gonadal Disorders |
|
|
Kidney Diseases |
|
|
Liver Diseases |
|
|
Neoplasms |
|
|
Neoplasms by Histologic Type |
|
|
Neoplasms by Site |
|
|
Neoplasms, Connective and Soft Tissue |
|
|
Neoplasms, Glandular and Epithelial |
|
|
Neoplasms, Nerve Tissue |
|
|
Neoplasms, Neuroepithelial |
|
|
Nervous System Diseases |
|
|
Neuroectodermal Tumors |
|
|
Neuroectodermal Tumors, Primitive |
|
|
Neuroectodermal Tumors, Primitive, Peripheral |
|
|
Ovarian Diseases |
|
|
Retinal Diseases |
|
|
Retinal Neoplasms |
|
|
Urogenital Neoplasms |
|
|
Urologic Diseases |
|
|
Urologic Neoplasms |
|
| 4 |
|
Interventions listed in this trial |
|
|
amifostine trihydrate |
|
|
busulfan |
|
|
filgrastim |
|
|
melphalan |
|
|
thiotepa |
|
| 5 |
|
Additional drug interventions recognized in this trial |
|
|
Amifostine |
|
| 6 |
|
More general drug interventions related to this trial |
|
|
Pharmacologic Actions |
|
|
Physiological Effects of Drugs |
|
|
Protective Agents |
|
|
Radiation-Protective Agents |
|
| 7 |
|
Sponsors listed in this trial |
|
|
Masonic Cancer Center, University of Minnesota |
